Significant of the unsatisfactory status of our present therapy for infection by tinea is the large number of remedies used in its treatment. Considering the increasing incidence of the disease, its marked tendency to recur and the frequency with which it persists in spite of prolonged treatment, comparatively few investigators have interested themselves in this particular problem of therapy. Apparently the first to do so were Bokorny1 in Germany, and Schamberg and Kolmer,2 in this country. Since the publication of these studies various investigators have demonstrated a range of clinical pictures far greater than was at first supposed to include the clinicopathologic possibilities of this ubiquitous organism. Thus, while this particular field of dermatology has received a certain amount of investigative attention, this attention has been directed more toward possible symptomatology than toward the therapeutic questions involved. A few investigators, however, have confined their efforts partially or wholly
KINGERY LB, WILLIAMS R, WOODWARD G. FURTHER STUDIES IN FUNGICIDES: COMPARATIVE EVALUATION OF PHENOL DERIVATIVES BY MODIFIED LABORATORY PROCEDURE. Arch Derm Syphilol. 1935;31(4):452–460. doi:10.1001/archderm.1935.01460220010002
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.